Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-241
Closed -$7.31K – 521
2025
Q3
$7.31K Hold
241
– – ﹤0.01% 1105
2025
Q2
$7.56K Hold
241
– – ﹤0.01% 1118
2025
Q1
$9.21K Hold
241
– – ﹤0.01% 1030
2024
Q4
$10.6K Hold
241
– – 0.01% 971
2024
Q3
$10.4K Hold
241
– – 0.01% 1004
2024
Q2
$10.9K Hold
241
– – 0.01% 983
2024
Q1
$15.1K Buy
+241
New +$14.4K 0.01% 856

Other funds holding ENOV

Rise Advisors's ENOV Position: Q4 2025 in Review

Rise Advisors sold out of Enovis (ENOV) in Q4 2025, closing a stake of 241 shares — an estimated $7.31K sold.

Rise Advisors first reported a position in ENOV in Q1 2024 and held it in 7 quarters. The position peaked at $15.1K in Q1 2024. 254 funds tracked by Wall St. Rank hold ENOV as of Q4 2025.

  • Rise Advisors reported no remaining Enovis position as of Q4 2025 after selling out during the quarter.
  • Rise Advisors sold 241 Enovis shares in Q4 2025, an estimated $7.31K.
  • Rise Advisors first reported a position in Enovis in Q1 2024 and held it in 7 quarters.
  • Rise Advisors's Enovis position peaked at $15.1K in Q1 2024.
  • 254 funds tracked by Wall St. Rank held Enovis as of Q4 2025.

Based on Rise Advisors's 13F filing for Q4 2025, filed 11 Feb 2026.